Medico Intercontinental Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1000280, "name": "Medico Intercon.", "stock_name": "Medico Intercon.", "full_name": "Medico Intercontinental Ltd", "name_url": "stocks-analysis/medico-intercon", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "28.90", "chg": 1.2, "chgp": "4.33%", "dir": 1, "prev_price": "27.70", "mcapval": "29.00 Cr", "mcap": "Micro Cap", "scripcode": 539938, "symbol": "", "ind_name": "Trading & Distributors", "ind_code": 5, "sector_id": 79, "indexname": "India SENSEX", "isin": "INE858Q01019", "curr_date": "Jul 10, 01:45 PM", "curr_time": "14:12 PM", "last_traded_at": "Jul 10, 01:45 PM IST", "bse_nse_vol": "1 ", "exc_status": "Active", "traded_date": "Jul 10, 2026", "traded_date_str": "2026 07 10", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medico-intercon-1000280-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Medico Intercontinental Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-intercontinental-ltd-is-rated-strong-sell-4096355", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MedicoIntercont_mojoScore_4096355.png", "date": "2026-07-10 10:10:30", "description": "Medico Intercontinental Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 August 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 10 July 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Medico Intercontinental Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-intercontinental-ltd-is-rated-strong-sell-4073077", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MedicoIntercont_mojoScore_4073077.png", "date": "2026-06-25 10:10:38", "description": "Medico Intercontinental Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 June 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Medico Intercontinental Ltd Falls to 52-Week Low of Rs 20.61 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-intercontinental-ltd-stock-falls-to-52-week-low-of-rs2061-4030823", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MedicoIntercont_priceRelatedfactors_4030823.png", "date": "2026-06-02 11:11:42", "description": "For the fourth consecutive session, Medico Intercontinental Ltd has declined, culminating in a fresh 52-week low of Rs 20.61 on 2 Jun 2026. This marks a near 50% drop over the past year, significantly underperforming the broader Sensex, which itself is hovering close to its own 52-week low." }, { "title": "Medico Intercontinental Ltd Gains 1.34%: Key Financial and Valuation Challenges Shape Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-intercontinental-ltd-gains-134-key-financial-and-valuation-challenges-shape-week-4022888", "imagepath": "", "date": "2026-05-30 13:04:58", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Flat quarterly performance reported with highest-ever net sales of ₹22.49 crores</p>\n <p><strong>25 May:</strong> Valuation reassessment highlights deteriorating financial metrics and elevated risk</p>\n <p><strong>26 May:</strong> Sharp price gain of 7.24% on heavy volume despite Sensex decline</p>\n <p><strong>27 May:</strong> Price correction of -3.96% amid mixed market sentiment</p>\n <p><strong>29 May:</strong> Week closes at Rs.21.88, up 1.34% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-labe..." }, { "title": "Medico Intercontinental Ltd Faces Valuation Reassessment Amid Deteriorating Metrics", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-intercontinental-ltd-faces-valuation-reassessment-amid-deteriorating-metrics-4009865", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MedicoIntercont_valuationdot_4009865.png", "date": "2026-05-25 08:01:18", "description": "Medico Intercontinental Ltd, a micro-cap player in the Trading & Distributors sector, has seen a marked deterioration in its valuation parameters, prompting a downgrade to a Strong Sell rating. With its price-to-earnings ratio plunging into negative territory and price-to-book value remaining low, the stock’s price attractiveness has shifted from very expensive to risky, signalling caution for investors amid sustained underperformance against benchmark indices." }, { "title": "Medico Intercontinental Ltd Reports Flat Quarterly Performance Amidst Financial Struggles", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-intercontinental-ltd-reports-flat-quarterly-performance-amidst-financial-struggles-4009760", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MedicoIntercont_fintrenddot_4009760.png", "date": "2026-05-25 08:00:23", "description": "Medico Intercontinental Ltd, a micro-cap player in the Trading & Distributors sector, has reported a flat financial performance for the quarter ended March 2026, signalling a pause in its previously negative trend. Despite achieving its highest quarterly net sales at ₹22.49 crores, the company continues to grapple with elevated debt levels and a deteriorating stock price, reflecting ongoing challenges in its operational and market positioning." }, { "title": "Are Medico Intercontinental Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-medico-intercontinental-ltd-latest-results-good-or-bad-4008973", "imagepath": "", "date": "2026-05-23 19:24:22", "description": "Medico Intercontinental Ltd's latest financial results for Q4 FY26 reveal a company grappling with significant operational challenges. The consolidated net profit for the quarter stood at a loss of ₹0.65 crores, marking a substantial decline compared to the previous year. Despite achieving net sales of ₹22.49 crores, which reflects a year-on-year growth of 6.29% and a quarter-on-quarter improvement of 13.30%, this revenue growth was insufficient to counteract severe margin compression and rising costs.\n\nThe company's profit after tax (PAT) margin fell to -10.45%, a stark contrast to the positive margin of 5.43% reported in Q4 FY25. This indicates considerable operational distress, compounded by a significant increase in interest expenses, which surged to ₹1.85 crores from ₹0.30 crores year-on-year. The return on equity (ROE) has also plummeted to a mere 0.02%, highlighting the company's inability to generat..." }, { "title": "Medico Intercontinental Falls 6.09%: Key Factors Behind the Steep Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-intercontinental-falls-609-key-factors-behind-the-steep-decline-4008291", "imagepath": "", "date": "2026-05-23 14:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 18:</strong> Stock opens at Rs.22.99, flat on the day</p>\n <p><strong>May 19:</strong> Sharp decline of 4.35% to Rs.21.99</p>\n <p><strong>May 21:</strong> Brief recovery with 4.10% gain to Rs.22.87</p>\n <p><strong>May 22:</strong> Stock hits 52-week low at Rs.20.81, closes at Rs.21.59 (-5.60%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.22.99</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.21.59</div><div class=\"stat-..." }, { "title": "Medico Intercontinental Q4 FY26: Steep Losses Raise Serious Questions About Business Viability", "link": "https://www.marketsmojo.com/news/result-analysis/medico-intercontinental-q4-fy26-steep-losses-raise-serious-questions-about-business-viability-4007216", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MedicoIntercont_quaterlyResult_4007216.png", "date": "2026-05-22 18:46:58", "description": "Medico Intercontinental Limited, a micro-cap pharmaceutical trading company, reported a consolidated net loss of ₹0.65 crores for Q4 FY26, marking a dramatic reversal from the ₹1.17 crores profit recorded in the same quarter last year. The 155.56% year-on-year decline and 195.45% quarter-on-quarter deterioration signal deepening operational distress that has persisted throughout FY26. With a market capitalisation of just ₹23.00 crores and the stock trading at ₹21.59—down 5.6% on the day—investor confidence appears to be evaporating rapidly." } ], "total": 151, "sid": "1000280", "stock_news_url": "https://www.marketsmojo.com/news/medico-intercontinental-1000280" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "29-Jun-2026", "details": "Closure of Trading Windo", "source": "BSE" }, { "caption": "Updates - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015", "datetime": "25-Jun-2026", "details": "Submission of Disclosure", "source": "BSE" }, { "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011", "datetime": "25-Jun-2026", "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Samir Shah & PACs", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Medico Intercontinental Ltd has declared <strong>1%</strong> dividend, ex-date: 23 Jun 23", "dt": "2023-06-23", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Flat quarterly performance reported with highest-ever net sales of ₹22.49 crores

25 May: Valuation reassessment highlights deteriorating financial metrics and elevated risk

26 May: Sharp price gain of 7.24% on heavy volume despite Sensex decline

27 May: Price correction of -3.96% amid mixed market sentiment

29 May: Week closes at Rs.21.88, up 1.34% for the week

Read full news article

Medico Intercontinental Ltd Faces Valuation Reassessment Amid Deteriorating Metrics

2026-05-25 08:01:18

Medico Intercontinental Ltd, a micro-cap player in the Trading & Distributors sector, has seen a marked deterioration in its valuation parameters, prompting a downgrade to a Strong Sell rating. With its price-to-earnings ratio plunging into negative territory and price-to-book value remaining low, the stock’s price attractiveness has shifted from very expensive to risky, signalling caution for investors amid sustained underperformance against benchmark indices.

Read full news article

Medico Intercontinental Ltd Reports Flat Quarterly Performance Amidst Financial Struggles

2026-05-25 08:00:23

Medico Intercontinental Ltd, a micro-cap player in the Trading & Distributors sector, has reported a flat financial performance for the quarter ended March 2026, signalling a pause in its previously negative trend. Despite achieving its highest quarterly net sales at ₹22.49 crores, the company continues to grapple with elevated debt levels and a deteriorating stock price, reflecting ongoing challenges in its operational and market positioning.

Read full news article

Are Medico Intercontinental Ltd latest results good or bad?

2026-05-23 19:24:22

Medico Intercontinental Ltd's latest financial results for Q4 FY26 reveal a company grappling with significant operational challenges. The consolidated net profit for the quarter stood at a loss of ₹0.65 crores, marking a substantial decline compared to the previous year. Despite achieving net sales of ₹22.49 crores, which reflects a year-on-year growth of 6.29% and a quarter-on-quarter improvement of 13.30%, this revenue growth was insufficient to counteract severe margin compression and rising costs. The company's profit after tax (PAT) margin fell to -10.45%, a stark contrast to the positive margin of 5.43% reported in Q4 FY25. This indicates considerable operational distress, compounded by a significant increase in interest expenses, which surged to ₹1.85 crores from ₹0.30 crores year-on-year. The return on equity (ROE) has also plummeted to a mere 0.02%, highlighting the company's inability to generat...

Read full news article

Medico Intercontinental Falls 6.09%: Key Factors Behind the Steep Decline

2026-05-23 14:00:04

Key Events This Week

May 18: Stock opens at Rs.22.99, flat on the day

May 19: Sharp decline of 4.35% to Rs.21.99

May 21: Brief recovery with 4.10% gain to Rs.22.87

May 22: Stock hits 52-week low at Rs.20.81, closes at Rs.21.59 (-5.60%)

Read full news article

Medico Intercontinental Q4 FY26: Steep Losses Raise Serious Questions About Business Viability

2026-05-22 18:46:58

Medico Intercontinental Limited, a micro-cap pharmaceutical trading company, reported a consolidated net loss of ₹0.65 crores for Q4 FY26, marking a dramatic reversal from the ₹1.17 crores profit recorded in the same quarter last year. The 155.56% year-on-year decline and 195.45% quarter-on-quarter deterioration signal deepening operational distress that has persisted throughout FY26. With a market capitalisation of just ₹23.00 crores and the stock trading at ₹21.59—down 5.6% on the day—investor confidence appears to be evaporating rapidly.

Read full news article

View All News